The fact
The French laboratory, specializing in cancer therapies, sees its trading volumes dwindle.
A regulatory or clinical failure could worsen the situation.
Click the link to read an article on the topic:
The French laboratory, specializing in cancer therapies, sees its trading volumes dwindle.
A regulatory or clinical failure could worsen the situation.